MELISSA LONGDEN: Open Payments
NPI 1336570969 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,805 in 95 payments from 13 companies in 2025. Trend: 2023 $1,223 · 2024 $1,469 · 2025 $1,805
Food & beverage: $1,805
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $518 |
| Janssen Biotech, Inc. | 10 | $253 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $198 |
| Lilly USA, LLC | 11 | $183 |
| Madrigal Pharmaceuticals | 6 | $178 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 7 | $124 |
| Phathom Pharmaceuticals, Inc. | 8 | $121 |
| Aimmune Therapeutics, Inc. | 4 | $95 |
| GENZYME CORPORATION | 1 | $35 |
| EVOKE PHARMA, INC. | 2 | $35 |
Products named: RINVOQ, TREMFYA, OMVOH, REZDIFFRA, LINZESS, XIFAXAN, ENTYVIO, VOQUEZNA.
Industry payments across TN — which companies pay providers there.
